Related Experiment Video

Updated: Jun 25, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

On-chip fragment-based approach for discovery of high-affinity bivalent inhibitors

Isao Miyazaki1, Siro Simizu, Keisuke Ishida

  • 1Antibiotics Laboratory and Chemical Biology Department, RIKEN, Wako, Saitama 351-0198, Japan.

Chembiochem : a European Journal of Chemical Biology
|February 20, 2009
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
06:17

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

Related Experiment Videos

Last Updated: Jun 25, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
06:17

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Articles linked to this work by shared authors, journal, and citation graph.

Two stress-responsive kinases suppress ferroptosis by activating antioxidant programs under mild oxidative stress.

Signal transduction and targeted therapy·2026

Structure-Activity-Property Relationships of MZ1-Based Trivalent PROTACs Incorporating a 1,2,5-Trisubstituted Benzene Linker.

Chemical & pharmaceutical bulletin·2026

Allantopyrone A promotes cross-linking of ubiquitin-specific protease 5 (USP5) and inhibits its deubiquitinase activity by targeting distinct domains.

The Journal of antibiotics·2026

Artificial intelligence-based phenotypic screening using Aspergillus oryzae identified a novel antifungal RK-1205-I.

The Journal of antibiotics·2026

Population-scale chemical response revealed by a barcoded yeast collection.

Nature communications·2026

Novel Ligands for the Orphan Receptor GPR151 Modulate Morphine Action.

Genes to cells : devoted to molecular & cellular mechanisms·2026

Spatiotemporally Resolved Tracking of Extracellular Vesicle Cargo via Photocatalytic Extracellular Vesicles Protein Tracking (PhoEVT).

Chembiochem : a European journal of chemical biology·2026

Reversible Redox-Responsive Peptide Condensates With RNA.

Chembiochem : a European journal of chemical biology·2026

DNA-Peptide Crosslinks Placed at Codon 249 of the p53 Tumor Suppressor Gene Induce G to A Transitions in Human Cells.

Chembiochem : a European journal of chemical biology·2026

Chemical Biology 2025: Highlights From the Ch/Bi145 Course at Caltech.

Chembiochem : a European journal of chemical biology·2026

Chelator Free Radiolabeling and Preclinical Evaluation of η6-Arene Sandwich Complexes of Lenalidomide With Rhenium and Technetium-99m.

Chembiochem : a European journal of chemical biology·2026

ω-Hydroxyacid Dehydrogenases From Clostridium viride: Iron-Containing Biocatalysts With Biotechnological Potential.

Chembiochem : a European journal of chemical biology·2026

In silico and in vitro evaluation of new sulfonamide derivatives as VEGFR-2 inhibitors for cancer therapy.

Future medicinal chemistry·2026

Spectrophotometric determination of levofloxacin using bromophenol blue: insight into the structure of the formed supramolecular complex.

RSC advances·2026

Solacanin C, a new pregnane steroid from Solanum torvum fruits: structural elucidation, potent α-glucosidase inhibition, and in silico ADMET profiling.

RSC advances·2026

Iodine-mediated 2,5-di(aryl/heteroaryl)-1,3,4-oxadiazoles: synthesis, and in vitro and in silico studies of anticancer and antifungal properties.

RSC advances·2026

Identification of chemicals targeting dementia genes and pathways in the Comparative Toxicogenomics Database.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Metabolic profiling reveals subtype-specific responses to jerantinine A acetate in breast cancer cells.

The Analyst·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us